AMI Cardiogenic Shock

Early Stabilization Can Improve Outcomes in Cardiogenic Shock

Explore the Education Library


Final Results from the NCSI Study Demonstrate the Benefit of Early Cardiac Unloading with Impella

The NCSI Study demonstrates a 71% survival to discharge with greater than 90% native heart recovery when best practices are used, including placement of an Impella heart pump prior to revascularization.


Achieving >70% AMI Cardiogenic Shock Survival: Insight from National Cardiogenic Shock Initiative (NCSI) Study

William O'Neill, MD, explains how cardiac power output (CPO) and pulmonary artery pulsatility index (PAPI) are used to drive care for patients after angioplasty.


Cardiogenic Shock Patients Can Achieve Heart Recovery

Dr. Shelley Hall, chief of transplant cardiology and mechanical support/heart failure at Baylor University Medical Center, discusses the challenges of creating trials to advance the science of cardiogenic shock.


This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].